Budget vs premium
Wellmedr vs He & She MD: Which Costs Less Over 12 Months? (2026)
Wellmedr costs $1,068 a year against $1,980 for He & She MD. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.4 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Wellmedr and He & She MD sit at ranks 5 and 25 in our weight loss listing, which makes them close enough to be a genuine decision rather than an obvious one.
The gap is 2.1x: $89/mo at Wellmedr, $191/mo at He & She MD. Neither number is unusual for the market, but paying the higher one only makes sense if you can name what it adds.
Each program is read on its own published terms first, then against the other on the four things that decide satisfaction: price, predictability, formulary and access to a clinician. Where a figure is not published, that is stated rather than estimated.
The short answer
- Lowest 12-month cost
- Wellmedr — $1,068 against $1,980 at He & She MD, on each provider's own best published pricing.
- Most predictable bill
- Wellmedr — Price locked for the life of the plan, so titration does not change what you are charged.
- Tirzepatide access
- He & She MD — Tirzepatide at $199/mo; the other side publishes semaglutide only.
- Widest medication choice
- He & She MD — compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.
Side-by-side comparison
Scan the pricing rows first, then the medication row. Those two settle most of these decisions between them.
| Wellmedr | He & She MD | |
|---|---|---|
| Advertised price | Semaglutide from $89/mo on the 1-year plan | Semaglutide from $139/mo, oral semaglutide and tirzepatide from $199/mo |
| Rate after promotions | $89/mo | $191/mo |
| Pricing structure | Price locked for the life of the plan | Introductory term, then renewal at a higher rate |
| Medication | Compounded semaglutide | Compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection |
| Support model | No coaching program stated | Coaching built into the plan |
| Shipping | Free overnight shipping | Free expedited shipping with no upcharges |
| Price transparency | Partly published | Published upfront |
| Tirzepatide | Not published | $199/mo |
| Patient reviews | 4,925 | 4,180 |
| eRxDoctor score | 9.4/10 | 7.0/10 |
Wellmedr vs He & She MD on total cost, not entry price
Both providers lead with a number designed to get you through the intake. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Wellmedr | He & She MD | |
|---|---|---|
| First month | $89 | $139 |
| Months 2 onward | $89/mo | $191/mo |
| 6-month total | $534 | $834 |
| 12-month total | $1,068 | $1,980 |
| Best published plan | No multi-month discount published | No multi-month discount published |
The twelve-month spread is $912. That is the number to hold He & She MD against: it has to justify roughly $76 extra every month.
Price escalation to plan for: He & She MD moves from $139 to $191, a 37% increase. Set a calendar reminder for the month it changes.
Where the extra money goes at He & She MD
He & She MD charges $191/mo where Wellmedr charges $89/mo. A premium is defensible only if it maps to something specific, so here is what He & She MD puts behind it: coaching app with 1:1 clinician messaging and progress tracking, no extra charge, and free expedited shipping with no upcharges.
Wellmedr's answer is locked-in pricing with no dose-based increases at one of the lowest published rates. What it does not carry: the $89 rate is tied to a one-year commitment and the platform publishes little else.
For a patient who has taken a GLP-1 before, knows how they titrate and needs a reliable monthly refill, the cheaper program is usually the correct one and the premium is a donation. For a first prescription, the calculus changes.
A closer look at Wellmedr
GLP-1 Plans Starting at Just $89/Month What it is really selling here is locked-in pricing with no dose-based increases at one of the lowest published rates.
Getting started means same-day review, after which free overnight shipping. Pricing runs on a price locked for the life of the plan basis, partly published.
Same-day clinician review. The formulary covers compounded semaglutide.
Wellmedr pros
- Lifetime locked-in pricing
- No dose-based price increases
Wellmedr cons
Against He & She MD specifically, the trade you are making: the $89 rate is tied to a one-year commitment and the platform publishes little else.
He & She MD in detail
He & She MD bundles compounded GLP-1 medication with a coaching app that carries 1:1 clinician messaging, GLP-1-specific guidance and progress tracking. Semaglutide injections start at $139/month, oral semaglutide and tirzepatide at $199/month, each a six-month introductory rate. Free expedited shipping, no membership fee, no insurance required. Against Wellmedr, that puts it in the position of the more expensive option.
The process is 2-3 minute intake with no payment required to check eligibility, then free expedited shipping with no upcharges. On money, expect introductory term, then renewal at a higher rate — published upfront.
Support: coaching app with 1:1 clinician messaging and progress tracking, no extra charge. The medications on offer are compounded semaglutide injection, oral semaglutide and compounded tirzepatide injection.
He & She MD pros
- Fast 2-3 minute intake with no payment required to check eligibility
- No membership fee stacked on top of the medication price
- Free expedited shipping on every order, with no shipping upcharges
- Named, dual board-certified obesity-medicine Chief Medical Officer
He & She MD cons
- Compounded GLP-1s are not reviewed by the FDA for safety, efficacy or quality
- The 15-25 lbs in 12 weeks figure is self-reported retrospective data, not trial data
- Headline prices are 6-month intro rates that renew 30-45% higher
Set beside Wellmedr, the thing to weigh: the headline rates are six-month terms that renew 30-45% higher.
Who should choose Wellmedr, and who should choose He & She MD
Choose Wellmedr if:
- the monthly rate is the constraint — $89/mo against $191/mo
- you want the price you sign up at to survive titration
- the twelve-month total is what you are optimizing ($1,068 against $1,980)
- what it leads on is worth paying for in your case: locked-in pricing with no dose-based increases at one of the lowest published rates
Choose He & She MD if:
- you want coaching app with 1:1 clinician messaging and progress tracking, no extra charge rather than a prescription alone
- you want tirzepatide available without changing provider later
- you would get real value from three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO
- you want the full price in front of you before completing an intake
Where each program concedes something
On price. Wellmedr is the cheaper program at $89/mo against $191/mo. What Wellmedr gives up for that is the $89 rate is tied to a one-year commitment and the platform publishes little else; what He & She MD charges for is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO.
On access. Wellmedr advertises same-day review and free overnight shipping; He & She MD advertises 2-3 minute intake with no payment required to check eligibility and free expedited shipping with no upcharges. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. Price locked for the life of the plan at Wellmedr, against introductory term, then renewal at a higher rate at He & She MD. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On clinical contact. The support models differ — same-day clinician review against coaching app with 1:1 clinician messaging and progress tracking, no extra charge — and that difference is felt in week two, not week one.
Evidence and regulatory status
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
Weight regain after withdrawal is the documented pattern: the STEP 1 extension recorded participants returning to close to their starting weight a year after stopping, per Diabetes, Obesity and Metabolism.
Compounding is lawful within a specific statutory framework, and the conditions attached to it have changed as GLP-1 shortages have resolved, per FDA.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Wellmedr vs He & She MD: common questions
Which is cheaper to start, Wellmedr or He & She MD?
Wellmedr, at $89 against $139. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Does the price go up as my dose increases?
At Wellmedr, no — locked-in pricing with no dose-based increases at one of the lowest published rates. At He & She MD, the published structure is introductory term, then renewal at a higher rate, moving from $139 to $191. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
Can I switch from Wellmedr to He & She MD later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge.
Is Wellmedr or He & She MD better for a first GLP-1 prescription?
For a first prescription, weight support over price. He & She MD offers more contact (coaching app with 1:1 clinician messaging and progress tracking, no extra charge), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
On the numbers, Wellmedr wins the year: $1,068 against $1,980. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where He & She MD justifies itself is three medication formats and a coaching app included, under a named board-certified obesity-medicine CMO. Where it does not is anywhere the extra spend buys features you will never open.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- TrimRx vs WellmedrBudget vs premium
- Shed vs WellmedrPublished price vs quote-only
- MedVi vs He & She MDCoaching-supported vs medication-only
- JoinFridays vs He & She MDCoaching-supported vs medication-only
- LIV Body vs Elevate HealthBudget vs premium
- LIV Body vs MaximusBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellmedr or He & She MD, and does not sell treatment. Read our ranking methodology.